SecBot SecBot
DEFA14A ·Filed Apr 21, 2026

CBIO

CRESCENT BIOPHARMA, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001628280-26-026285
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard proxy statement filing. Monitor for the meeting date and voting agenda, but no immediate trading implications are expected. The actual vote details will be in the full proxy materials, not this filing notice.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
CBIO ▼ -45.33% at T+60d
NEUTRAL call -45.33% · α vs SPY -50.11% · entry $26.98 → $14.75
Entry = T+0 close
Apr 21, 2026
via day close
T+1d
-4.74%
call -4.74% · α -4.35%
$25.70
settled 6mo ago
T+5d
-16.83%
call -16.83% · α -16.88%
$22.44
settled 6mo ago
T+20d
-31.50%
call -31.50% · α -34.67%
$18.48
settled 5mo ago
T+60d
-45.33%
call -45.33% · α -50.11%
$14.75
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Crescent Biopharma, Inc. (CBIO) has filed a definitive proxy statement (DEFA14A) for an upcoming shareholder meeting. The filing is routine and primarily administrative, with no material financial or strategic implications disclosed.

Key Financial Metrics

Vote
director election

Key Facts

  • Company: Crescent Biopharma, Inc. (CBIO)
  • Form Type: DEFA14A (Definitive Proxy Statement)
  • Filing Type: Routine administrative document for a shareholder meeting
  • No material financial data, strategic changes, or officer/director appointments disclosed in the provided content

Financial Impact

No material financial impact disclosed

revenueepsdebtdilution

Risk Factors

  • The filing notice itself contains no risk, but the underlying vote (e.g., on executive compensation) could be a risk factor if the outcome is unfavorable.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001628280-26-026285
Document: 0001628280-26-026285-index-headers.html0001628280-26-026285
Document: 0001628280-26-026285-index.html0001628280-26-026285
Document: 0001628280-26-026285.txt0001628280-26-026285
16 reports for CBIO
Performance horizon
75% Hit rate @ T+60 3 of 4 directional calls Went positive at some point 4 of 4 best @ T+60▲ +9.89%Jul 14, 2026
Filters
Rows
Reports for CBIO — sortable, filterable
TypeNow
Oct 15, 2026
12d ago
8-K
NEUTRAL ★ 3/10
$11.84awaiting T+60—$13.27 (+12.08%)
Oct 15, 2026
12d ago
Press Release
NEUTRAL ★ 4/10
$11.84awaiting T+60—$13.27 (+12.08%)
Oct 5, 2026
22d ago
Press Release
NEUTRAL ★ 4/10
$13.94awaiting T+60—$13.27 (−4.81%)
Sep 18, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$16.25awaiting T+60—$13.27 (−18.34%)
Jul 30, 2026
12w ago
8-K
NEUTRAL ★ 3/10
$15.02 $12.82▼ −14.65%▼ −17.11%$13.27 (−11.65%)
Jul 20, 2026
14w ago
Insider Buy
BULLISH ★ 7/10
$16.64 $12.91▼ −22.42%▼ −26.39%$13.27 (−20.25%)
Jul 15, 2026
14w ago
8-K / 424B5
BEARISH ★ 6/10
$15.11 $14.91▲ +1.32%▲ +5.03%$13.27 (+12.18%)
Jul 14, 2026
15w ago
Press Release
BEARISH ★ 7/10
$15.67 $14.12▲ +9.89%▲ +12.42%$13.27 (+15.32%)
Jul 14, 2026
15w ago
424B5
BEARISH ★ 6/10
$15.67 $14.12▲ +9.89%▲ +12.42%$13.27 (+15.32%)
Jul 13, 2026
15w ago
EFFECT
NEUTRAL ★ 3/10
$15.69 $13.57▼ −13.51%▼ −17.51%$13.27 (−15.42%)
Showing 10 of 16

US Market Status

Market Closed — Opens Thu (10h 21m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 21, 2026